Skip to main content
Premium Trial:

Request an Annual Quote

Bristol Myers-Squibb, Saladax Expand Companion Dx Deal to Include Ortho-Clinical Diagnostics

NEW YORK (GenomeWeb News) – Bristol Myers-Squibb and Saladax Biomedical today expanded an agreement covering companion diagnostics to include Johnson & Johnson's Ortho-Clinical Diagnostics.

The three firms will collaborate to develop and gain regulatory approval of certain diagnostic assays. Saladax and Ortho-Clinical have a separate agreement to commercialize assays resulting from the deal.

Financial and other terms of both deals were not disclosed.

Saladax and Bristol-Myers Squibb originally reached a partnership in May 2010 to develop clinical diagnostic tests for certain drug compounds in Bristol Myers-Squibb's pipeline. The terms of that deal called for the two firms to collaborate on development and regulatory approvals.

Saladax had exclusive global rights to commercialize assays developed from the collaboration.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.